Cargando…
Iron status markers in patients with small cell carcinoma of the lung. Relation to survival.
A longitudinal study of iron status markers (haemoglobin (Hb), serum (S-) iron, S-transferrin, transferrin saturation, S-ferritin) was performed in 31 chemotherapy treated patients with small cell lung cancer. At discovery, eight patients were anaemic (Hb less than 121 g l-1). Hb, S-iron and transfe...
Autores principales: | Milman, N., Sengeløv, H., Dombernowsky, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977453/ https://www.ncbi.nlm.nih.gov/pubmed/1657106 |
Ejemplares similares
-
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression
por: Lassen, U N, et al.
Publicado: (1999) -
Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up.
por: Osterlind, K., et al.
Publicado: (1986) -
Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
por: Sørensen, J B, et al.
Publicado: (1999) -
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001) -
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
por: Johnson, P. W., et al.
Publicado: (1993)